182 related articles for article (PubMed ID: 1684757)
21. Immunohistochemical study of kuru plaques using antibodies against synthetic prion protein peptides.
Hashimoto K; Mannen T; Nukina N
Acta Neuropathol; 1992; 83(6):613-7. PubMed ID: 1353279
[TBL] [Abstract][Full Text] [Related]
22. Positive transmission of Creutzfeldt-Jakob disease verified by murine kuru plaques.
Kitamoto T; Tateishi J; Sawa H; Doh-Ura K
Lab Invest; 1989 Apr; 60(4):507-12. PubMed ID: 2468821
[TBL] [Abstract][Full Text] [Related]
23. Towards authentic transgenic mouse models of heritable PrP prion diseases.
Watts JC; Giles K; Bourkas ME; Patel S; Oehler A; Gavidia M; Bhardwaj S; Lee J; Prusiner SB
Acta Neuropathol; 2016 Oct; 132(4):593-610. PubMed ID: 27350609
[TBL] [Abstract][Full Text] [Related]
24. Atypical Creutzfeldt-Jakob disease with PrP-amyloid plaques in white matter: molecular characterization and transmission to bank voles show the M1 strain signature.
Rossi M; Saverioni D; Di Bari M; Baiardi S; Lemstra AW; Pirisinu L; Capellari S; Rozemuller A; Nonno R; Parchi P
Acta Neuropathol Commun; 2017 Nov; 5(1):87. PubMed ID: 29169405
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of metallothioneins in human prion diseases.
Kawashima T; Doh-ura K; Torisu M; Uchida Y; Furuta A; Iwaki T
Dement Geriatr Cogn Disord; 2000; 11(5):251-62. PubMed ID: 10940676
[TBL] [Abstract][Full Text] [Related]
26. Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases.
Kobayashi A; Parchi P; Yamada M; Mohri S; Kitamoto T
Neuropathology; 2016 Jun; 36(3):305-10. PubMed ID: 26669818
[TBL] [Abstract][Full Text] [Related]
27. Creutzfeldt-Jakob disease patients with congophilic kuru plaques have the missense variant prion protein common to Gerstmann-Sträussler syndrome.
Doh-ura K; Tateishi J; Kitamoto T; Sasaki H; Sakaki Y
Ann Neurol; 1990 Feb; 27(2):121-6. PubMed ID: 2180366
[TBL] [Abstract][Full Text] [Related]
28. Accumulation of Astrocytic Aquaporin 4 and Aquaporin 1 in Prion Protein Plaques.
Sadashima S; Honda H; Suzuki SO; Shijo M; Aishima S; Kai K; Kira J; Iwaki T
J Neuropathol Exp Neurol; 2020 Apr; 79(4):419-429. PubMed ID: 32167542
[TBL] [Abstract][Full Text] [Related]
29. [Molecular biology of subacute spongiform encephalitis].
Catala M
Presse Med; 1991 Oct; 20(31):1506-10. PubMed ID: 1682916
[TBL] [Abstract][Full Text] [Related]
30. Immunochemical, molecular genetic, and transmission studies on a case of Gerstmann-Sträussler-Scheinker syndrome.
Tateishi J; Kitamoto T; Doh-ura K; Sakaki Y; Steinmetz G; Tranchant C; Warter JM; Heldt N
Neurology; 1990 Oct; 40(10):1578-81. PubMed ID: 1699173
[TBL] [Abstract][Full Text] [Related]
31. A comparative study of abnormal prion protein isoforms between Gerstmann-Sträussler-Scheinker syndrome and Creutzfeldt-Jakob disease.
Furukawa H; Doh-ura K; Kikuchi H; Tateishi J; Iwaki T
J Neurol Sci; 1998 Jun; 158(1):71-5. PubMed ID: 9667781
[TBL] [Abstract][Full Text] [Related]
32. A new point mutation of the PRNP gene in Gerstmann-Sträussler-Scheinker case in Poland.
Bratosiewicz J; Barcikowska M; Cervenakowa L; Brown P; Gajdusek DC; Liberski PP
Folia Neuropathol; 2000; 38(4):164-6. PubMed ID: 11693719
[TBL] [Abstract][Full Text] [Related]
33. A case of sporadic Creutzfeldt-Jakob disease with a Gerstmann-Sträussler-Scheinker phenotype but no alterations in the PRNP gene.
Liberski PP; Barcikowska M; Cervenakova L; Bratosiewicz J; Marczewska M; Brown P; Gajdusek DC
Acta Neuropathol; 1998 Oct; 96(4):425-30. PubMed ID: 9797009
[TBL] [Abstract][Full Text] [Related]
34. Brain biopsy in Creutzfeldt-Jakob disease: evolution of pathological changes by prion protein immunohistochemistry.
Mahadevan A; Shankar SK; Yasha TC; Santosh V; Sarkar C; Desai AP; Satishchandra P
Neuropathol Appl Neurobiol; 2002 Aug; 28(4):314-24. PubMed ID: 12175344
[TBL] [Abstract][Full Text] [Related]
35. An amber mutation of prion protein in Gerstmann-Sträussler syndrome with mutant PrP plaques.
Kitamoto T; Iizuka R; Tateishi J
Biochem Biophys Res Commun; 1993 Apr; 192(2):525-31. PubMed ID: 8097911
[TBL] [Abstract][Full Text] [Related]
36. The primary structure of the prion protein influences the distribution of abnormal prion protein in the central nervous system.
Kitamoto T; Doh-ura K; Muramoto T; Miyazono M; Tateishi J
Am J Pathol; 1992 Aug; 141(2):271-7. PubMed ID: 1353945
[TBL] [Abstract][Full Text] [Related]
37. Genetic and infectious prion diseases.
Prusiner SB
Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
[TBL] [Abstract][Full Text] [Related]
38. N-terminal sequence of prion protein is also integrated into kuru plaques in patients with Gerstmann-Sträussler syndrome.
Kitamoto T; Muramoto T; Hilbich C; Beyreuther K; Tateishi J
Brain Res; 1991 Apr; 545(1-2):319-21. PubMed ID: 1677605
[TBL] [Abstract][Full Text] [Related]
39. Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques.
Sasaki N; Takeuchi M; Chowei H; Kikuchi S; Hayashi Y; Nakano N; Ikeda H; Yamagishi S; Kitamoto T; Saito T; Makita Z
Neurosci Lett; 2002 Jun; 326(2):117-20. PubMed ID: 12057842
[TBL] [Abstract][Full Text] [Related]
40. Prions and prion diseases of the central nervous system.
Tyler KL
Curr Clin Top Infect Dis; 1999; 19():226-51. PubMed ID: 10472489
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
